| Sharon Elaine Patterson, OTR/L CHT | |
|
2901 174th St Ne, Marysville, WA 98271-4743 | |
| (360) 454-1900 | |
| Not Available |
| Full Name | Sharon Elaine Patterson |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 43 Years |
| Location | 2901 174th St Ne, Marysville, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235200650 | NPI | - | NPPES |
| 4176PA | Other | WA | REGENCE BLUE SHIELD |
| 8343286 | Medicaid | WA | |
| 0357106 | Other | WA | L & I |
| 9348286 | Medicaid | WA | |
| 4671PA | Other | WA | REGENCE BLUE SHIELD |
| 5040095 | Other | WA | AETNA |
| 0368143 | Other | WA | L & I |
| 0215186 | Other | WA | DEPT OF LABOR & INDUSTRY |
| 8943189 | Other | WA | L&I CRIME VICTIMS |
| 0357088 | Other | WA | L & I |
| 5476PA | Other | WA | REGENCE BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XH1200X | Occupational Therapist - Hand | OT00001635 (Washington) | Secondary |
| 225X00000X | Occupational Therapist | OT00001635 (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Everett Clinic Pllc | 6406752153 | 552 |
News Archive
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
Why the females of some species undergo menopause while others do not has always been a conundrum despite our understanding of the biological mechanisms involved.
PulseOximetersDIRECT.com, the leading online retailer of portable Pulse Oximeter products introduces today the new, affordable $39 FDA approved Landon Medical LM-800 Finger Pulse Oximeter for home use.
University Hospitals (UH) Bedford Medical Center, a campus of UH Regional Hospitals, has launched a new program to help older adults live healthier, more independent lives.
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona.
› Verified 6 days ago
| Provider Name | The Everett Clinic Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1831186766 PECOS PAC ID: 6406752153 Enrollment ID: O20031211000922 |
News Archive
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
Why the females of some species undergo menopause while others do not has always been a conundrum despite our understanding of the biological mechanisms involved.
PulseOximetersDIRECT.com, the leading online retailer of portable Pulse Oximeter products introduces today the new, affordable $39 FDA approved Landon Medical LM-800 Finger Pulse Oximeter for home use.
University Hospitals (UH) Bedford Medical Center, a campus of UH Regional Hospitals, has launched a new program to help older adults live healthier, more independent lives.
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona.
› Verified 6 days ago
| Provider Name | South Sound Physical & Hand Therapy Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1548217631 PECOS PAC ID: 6709774631 Enrollment ID: O20040310000846 |
News Archive
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
Why the females of some species undergo menopause while others do not has always been a conundrum despite our understanding of the biological mechanisms involved.
PulseOximetersDIRECT.com, the leading online retailer of portable Pulse Oximeter products introduces today the new, affordable $39 FDA approved Landon Medical LM-800 Finger Pulse Oximeter for home use.
University Hospitals (UH) Bedford Medical Center, a campus of UH Regional Hospitals, has launched a new program to help older adults live healthier, more independent lives.
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona.
› Verified 6 days ago
| Provider Name | Snohomish Physical Therapy Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1487692398 PECOS PAC ID: 3476547100 Enrollment ID: O20040414000418 |
News Archive
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
Why the females of some species undergo menopause while others do not has always been a conundrum despite our understanding of the biological mechanisms involved.
PulseOximetersDIRECT.com, the leading online retailer of portable Pulse Oximeter products introduces today the new, affordable $39 FDA approved Landon Medical LM-800 Finger Pulse Oximeter for home use.
University Hospitals (UH) Bedford Medical Center, a campus of UH Regional Hospitals, has launched a new program to help older adults live healthier, more independent lives.
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sharon Elaine Patterson, OTR/L CHT Po Box 5127, Everett, WA 98206-5127 Ph: (360) 454-1900 | Sharon Elaine Patterson, OTR/L CHT 2901 174th St Ne, Marysville, WA 98271-4743 Ph: (360) 454-1900 |
News Archive
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
Why the females of some species undergo menopause while others do not has always been a conundrum despite our understanding of the biological mechanisms involved.
PulseOximetersDIRECT.com, the leading online retailer of portable Pulse Oximeter products introduces today the new, affordable $39 FDA approved Landon Medical LM-800 Finger Pulse Oximeter for home use.
University Hospitals (UH) Bedford Medical Center, a campus of UH Regional Hospitals, has launched a new program to help older adults live healthier, more independent lives.
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona.
› Verified 6 days ago
Savannah Lynn Roberts, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4317 76th St Ne, Marysville, WA 98270 Phone: 360-965-0225 | |
Peggy Ann Jensen, OCCUPATIONAL THERAPI Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th St Ne, Marysville, WA 98270 Phone: 360-653-0800 | |
Irg Physical & Hand Therapy - Smokey Point Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2707 171st Pl Ne Ste 101, Marysville, WA 98271 Phone: 360-386-7401 Fax: 360-386-7402 | |
Marysville Physical Therapy Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 919 State Ave, Suite 101, Marysville, WA 98270 Phone: 360-386-7405 Fax: 360-386-7406 | |
Tamsie M Aalbu, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6618 64th St Ne Ste D, Marysville, WA 98270 Phone: 360-653-5800 | |
Colleen Marie Cotroneo, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th St Ne, Marysville, WA 98270 Phone: 360-657-6664 |